These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27798205)

  • 1. Community carriage of ESBL-producing Escherichia coli is associated with strains of low pathogenicity: a Swedish nationwide study.
    Ny S; Löfmark S; Börjesson S; Englund S; Ringman M; Bergström J; Nauclér P; Giske CG; Byfors S
    J Antimicrob Chemother; 2017 Feb; 72(2):582-588. PubMed ID: 27798205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and patient related factors associated with Extended-Spectrum Beta-Lactamase producing Escherichia coli and Klebsiella pneumoniae carriage and infection among pediatric patients in Tanzania.
    Letara N; Ngocho JS; Karami N; Msuya SE; Nyombi B; Kassam NA; Skovbjerg S; Åhren C; Philemon R; Mmbaga BT
    Sci Rep; 2021 Nov; 11(1):22759. PubMed ID: 34815472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors.
    Titelman E; Hasan CM; Iversen A; Nauclér P; Kais M; Kalin M; Giske CG
    Clin Microbiol Infect; 2014 Aug; 20(8):O508-15. PubMed ID: 24450760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESBL-producing Escherichia coli ST131 versus non-ST131: evolution and risk factors of carriage among French children in the community between 2010 and 2015.
    Birgy A; Levy C; Bidet P; Thollot F; Derkx V; Béchet S; Mariani-Kurkdjian P; Cohen R; Bonacorsi S
    J Antimicrob Chemother; 2016 Oct; 71(10):2949-56. PubMed ID: 27330068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTX-M-15-non-ST131 Escherichia coli isolates are mainly responsible of faecal carriage with ESBL-producing Enterobacteriaceae in travellers, immigrants and those visiting friends and relatives.
    Valverde A; Turrientes MC; Norman F; San Martín E; Moreno L; Pérez-Molina JA; López-Vélez R; Cantón R
    Clin Microbiol Infect; 2015 Mar; 21(3):252.e1-4. PubMed ID: 25658550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum β-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre.
    Nicolas-Chanoine MH; Gruson C; Bialek-Davenet S; Bertrand X; Thomas-Jean F; Bert F; Moyat M; Meiller E; Marcon E; Danchin N; Noussair L; Moreau R; Leflon-Guibout V
    J Antimicrob Chemother; 2013 Mar; 68(3):562-8. PubMed ID: 23143897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent acquisition of low-virulence strains of ESBL-producing Escherichia coli in travellers.
    Vading M; Kabir MH; Kalin M; Iversen A; Wiklund S; Nauclér P; Giske CG
    J Antimicrob Chemother; 2016 Dec; 71(12):3548-3555. PubMed ID: 27566312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology.
    Rodríguez-Baño J; López-Cerero L; Navarro MD; Díaz de Alba P; Pascual A
    J Antimicrob Chemother; 2008 Nov; 62(5):1142-9. PubMed ID: 18641033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of CTX-M extended-spectrum beta-lactamases and sequence type 131 in Korean blood, urine, and rectal Escherichia coli isolates.
    Graham SE; Zhang L; Ali I; Cho YK; Ismail MD; Carlson HA; Foxman B
    Infect Genet Evol; 2016 Jul; 41():292-295. PubMed ID: 27101781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal carriage of Extended Spectrum Beta-Lactamase producing E. coli in women with urinary tract infections, Cameroon.
    Djuikoue IC; Woerther PL; Toukam M; Burdet C; Ruppé E; Gonsu KH; Fokunang C; El Mniai A; Larissa K; Pieme AC; Mboupaing MG; Kakam CM; Fogang HK; Andremont A; Ngogang J
    J Infect Dev Ctries; 2016 Oct; 10(10):1135-1139. PubMed ID: 27801378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subsequent infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in patients with prior infection or fecal colonization.
    Lindblom A; Karami N; Magnusson T; Åhrén C
    Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1491-1497. PubMed ID: 29796984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and quinolone resistance of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli in 6 communities and 2 physical examination center populations in Shanghai, China.
    Ni Q; Tian Y; Zhang L; Jiang C; Dong D; Li Z; Mao E; Peng Y
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):428-433. PubMed ID: 27681363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli.
    Rooney PJ; O'Leary MC; Loughrey AC; McCalmont M; Smyth B; Donaghy P; Badri M; Woodford N; Karisik E; Livermore DM
    J Antimicrob Chemother; 2009 Sep; 64(3):635-41. PubMed ID: 19549667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ESBL-producing Escherichia coli isolated from bloodstream infections--antimicrobial susceptibility, conjugative transfer of resistance genes and phylogenetic origin.
    Franiczek R; Krzyżanowska B
    Adv Clin Exp Med; 2014; 23(6):865-70. PubMed ID: 25618110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark.
    Hansen F; Olsen SS; Heltberg O; Justesen US; Fuglsang-Damgaard D; Knudsen JD; Hammerum AM
    Microb Drug Resist; 2014 Aug; 20(4):316-24. PubMed ID: 24517383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli.
    Can F; Kurt-Azap Ö; İspir P; Nurtop E; Seref C; Loçlar İ; Aktaş ON; Orhan YC; Ergonul O
    J Glob Antimicrob Resist; 2016 Mar; 4():49-52. PubMed ID: 27436393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal carriage rates of extended-spectrum β-lactamase-producing Escherichia coli among antibiotic naive healthy human volunteers.
    Mathai D; Kumar VA; Paul B; Sugumar M; John KR; Manoharan A; Kesavan LM
    Microb Drug Resist; 2015 Feb; 21(1):59-64. PubMed ID: 25127253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain.
    Merino I; Shaw E; Horcajada JP; Cercenado E; Mirelis B; Pallarés MA; Gómez J; Xercavins M; Martínez-Martínez L; De Cueto M; Cantón R; Ruiz-Garbajosa P;
    J Antimicrob Chemother; 2016 Aug; 71(8):2125-30. PubMed ID: 27494832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes.
    Morales-Barroso I; López-Cerero L; Molina J; Bellido M; Navarro MD; Serrano L; González-Galán V; Praena J; Pascual A; Rodríguez-Baño J
    Int J Antimicrob Agents; 2017 Apr; 49(4):498-502. PubMed ID: 28257756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Escherichia coli ST131 clonal complex (ST705) and Klebsiella pneumoniae ST15 among faecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae.
    Ríos E; López MC; Rodríguez-Avial I; Culebras E; Picazo JJ
    J Med Microbiol; 2017 Feb; 66(2):169-174. PubMed ID: 27902381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.